Skip to main content
PMC home page
Heart logoLink to Heart
. 2005 Dec;91(Suppl 6):vi1–vi27. doi: 10.1136/hrt.2005.061457

Percutaneous coronary intervention: recommendations for good practice and training

K Dawkins, T Gershlick, M de Belder, A Chauhan, G Venn, P Schofield, D Smith, J Watkins, H Gray, W Joint
PMCID: PMC1876395  PMID: 16365340

Abstract

Cardiologists undertaking percutaneous coronary intervention (PCI) are excited by the combination of patient and physician satisfaction and technological advance occurring on the background of the necessary manual dexterity. Progress and applicability of percutaneous techniques since their inception in 1977 have been remarkable; a sound evidence base coupled with the enthusiasm and ingenuity of the medical device industry has resulted in a sea change in the treatment of coronary heart disease (CHD), which continues to evolve at breakneck speed.

This is the third set of guidelines produced by the British Cardiovascular Intervention Society and the British Cardiac Society.1,2 Following the last set of guidelines published in 2000, we have seen PCI activity in the UK increase from 33 652 to 62 780 (87% in four years) such that the PCI to coronary artery bypass grafting ratio has increased to 2.5:1. The impact of drug eluting stents has been profound, and the Department of Health is investigating the feasibility of primary PCI for acute myocardial infarction. Nevertheless, the changes in the structure of National Health Service funding are likely to focus our attention on cost effective treatments and will require physician engagement and sensitive handling if we are to continue the rapid and appropriate growth in our chosen field.3

It is important with this burgeoning development now occurring on a broad front (in both regional centres and district general hospitals) that we maintain our vigilance on audit and outcome measures so that standards are maintained for both operators and institutions alike. This set of guidelines includes new sections on training, informed consent, and a core evidence base, which we hope you will find useful and informative.

Keith D Dawkins:

President, British Cardiovascular Intervention Society (2000–2004)

Huon H Gray:

President, British Cardiac Society (2003–2005)

Full Text

The Full Text of this article is available as a PDF (277.5 KB).

Figure 1.

Figure 1

Open in a new tab

 Isolated coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in the UK. Source: Society of Cardiothoracic Surgeons of Great Britain, British Cardiovascular Intervention Society.

Figure 2.

Figure 2

Open in a new tab

 Relation between stent use and the requirement for emergency CABG. Source: British Cardiovascular Intervention Society.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atmaca Yusuf, Altin Timuçin, Ozdöl Sadi Cagdas, Guleç Sadi, Pamir Gülgün, Oral Dervis. Direct stent implantation in acute coronary syndrome. J Invasive Cardiol. 2002 Jun;14(6):308–312. [PubMed] [Google Scholar]
  2. Baim Donald S., Wahr Dennis, George Barry, Leon Martin B., Greenberg Joel, Cutlip Donald E., Kaya Unsal, Popma Jeffrey J., Ho Kalon K. L., Kuntz Richard E. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002 Mar 19;105(11):1285–1290. [PubMed] [Google Scholar]
  3. Bech G. J., De Bruyne B., Pijls N. H., de Muinck E. D., Hoorntje J. C., Escaned J., Stella P. R., Boersma E., Bartunek J., Koolen J. J. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001 Jun 19;103(24):2928–2934. doi: 10.1161/01.cir.103.24.2928. [DOI] [PubMed] [Google Scholar]
  4. Bertinchant J. P., Polge A., Ledermann B., Genet L., Fabbro-Peray P., Raczka F., Brunet J., Poirey S., Wittenberg O., Pernel I. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 1999 Jul 1;84(1):51–57. doi: 10.1016/s0002-9149(99)00191-5. [DOI] [PubMed] [Google Scholar]
  5. Bertrand M. E., Rupprecht H. J., Urban P., Gershlick A. H., CLASSICS Investigators Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation. 2000 Aug 8;102(6):624–629. doi: 10.1161/01.cir.102.6.624. [DOI] [PubMed] [Google Scholar]
  6. Bertrand M. E., Simoons M. L., Fox K. A., Wallentin L. C., Hamm C. W., McFadden E., de Feyter P. J., Specchia G., Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000 Sep;21(17):1406–1432. doi: 10.1053/euhj.2000.2301. [DOI] [PubMed] [Google Scholar]
  7. Bertrand Michel E., Simoons Maarten L., Fox Keith A. A., Wallentin Lars C., Hamm Christian W., McFadden Eugene, De Feyter Pim J., Specchia Giuseppe, Ruzyllo Witold, Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002 Dec;23(23):1809–1840. doi: 10.1053/euhj.2002.3385. [DOI] [PubMed] [Google Scholar]
  8. Bhatt D. L., Marso S. P., Lincoff A. M., Wolski K. E., Ellis S. G., Topol E. J. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000 Mar 15;35(4):922–928. doi: 10.1016/s0735-1097(99)00650-6. [DOI] [PubMed] [Google Scholar]
  9. Black A., Cortina R., Bossi I., Choussat R., Fajadet J., Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001 Mar 1;37(3):832–838. doi: 10.1016/s0735-1097(00)01176-1. [DOI] [PubMed] [Google Scholar]
  10. Braun Peter, Stroh Erika, Heinrich Karl-Wilhelm. Rotablator versus cutting balloon for the treatment of long in-stent restenoses. J Invasive Cardiol. 2002 Jun;14(6):291–296. [PubMed] [Google Scholar]
  11. Brito Fábio S., Jr, Caixeta Adriano M., Perin Marco A., Rati Miguel, Arruda J. Airton, Cantarelli Marcelo, Castello Hélio, Jr, Machado Bruno M., Silva Lélio A., Ribeiro Expedito E. Comparison of direct stenting versus stenting with predilation for the treatment of selected coronary narrowings. Am J Cardiol. 2002 Jan 15;89(2):115–120. doi: 10.1016/s0002-9149(01)02185-3. [DOI] [PubMed] [Google Scholar]
  12. Brueren B. R. G., Ernst J. M. P. G., Suttorp M. J., ten Berg J. M., Rensing B. J. W. M., Mast E. G., Bal E. T., Six A. J., Plokker H. W. M. Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines? Heart. 2003 Nov;89(11):1336–1339. doi: 10.1136/heart.89.11.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Buller C. E., Dzavik V., Carere R. G., Mancini G. B., Barbeau G., Lazzam C., Anderson T. J., Knudtson M. L., Marquis J. F., Suzuki T. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation. 1999 Jul 20;100(3):236–242. doi: 10.1161/01.cir.100.3.236. [DOI] [PubMed] [Google Scholar]
  14. Cannon C. P., Gibson C. M., Lambrew C. T., Shoultz D. A., Levy D., French W. J., Gore J. M., Weaver W. D., Rogers W. J., Tiefenbrunn A. J. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000 Jun 14;283(22):2941–2947. doi: 10.1001/jama.283.22.2941. [DOI] [PubMed] [Google Scholar]
  15. Cannon C. P., Weintraub W. S., Demopoulos L. A., Robertson D. H., Gormley G. J., Braunwald E. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction. Am J Cardiol. 1998 Sep 15;82(6):731–736. doi: 10.1016/s0002-9149(98)00540-2. [DOI] [PubMed] [Google Scholar]
  16. Chan Albert W., Chew Derek P., Bhatt Deepak L., Moliterno David J., Topol Eric J., Ellis Stephen G. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2002 Jan 15;89(2):132–136. doi: 10.1016/s0002-9149(01)02188-9. [DOI] [PubMed] [Google Scholar]
  17. Chan Albert W., Moliterno David J., Berger Peter B., Stone Gregg W., DiBattiste Peter M., Yakubov Steven L., Sapp Shelly K., Wolski Kathy, Bhatt Deepak L., Topol Eric J. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol. 2003 Oct 1;42(7):1188–1195. doi: 10.1016/s0735-1097(03)00944-6. [DOI] [PubMed] [Google Scholar]
  18. Cisowski M., Morawski W., Drzewiecki J., Bochenek A. Integrated Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) grafting and angioplasty for coronary artery revascularization. Heart Surg Forum. 2002;5 (Suppl 4):S282–S295. [PubMed] [Google Scholar]
  19. Colombo Antonio, Drzewiecki Janusz, Banning Adrian, Grube Eberhard, Hauptmann Karl, Silber Sigmund, Dudek Dariusz, Fort Stephen, Schiele Francois, Zmudka Krysztof. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003 Aug 4;108(7):788–794. doi: 10.1161/01.CIR.0000086926.62288.A6. [DOI] [PubMed] [Google Scholar]
  20. Colombo Antonio, Stankovic Goran, Orlic Dejan, Corvaja Nicola, Liistro Francesco, Airoldi Flavio, Chieffo Alaide, Spanos Vassilis, Montorfano Matteo, Di Mario Carlo. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv. 2003 Oct;60(2):145–151. doi: 10.1002/ccd.10622. [DOI] [PubMed] [Google Scholar]
  21. Costa Ricardo, Joyal Michel, Harel Francois, Fox Tim, Crocker Ian, Arsenault Andre, Gregoire Jean, Bonan Raoul. Treatment of bifurcation in-stent restenotic lesions with beta radiation using strontium 90 and sequential positioning pullback technique: procedural details and clinical outcomes. J Invasive Cardiol. 2003 Aug;15(8):469–474. [PubMed] [Google Scholar]
  22. Cutlip D. E., Leon M. B., Ho K. K., Gordon P. C., Giambartolomei A., Diver D. J., Lasorda D. M., Williams D. O., Fitzpatrick M. M., Desjardin A. Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. J Am Coll Cardiol. 1999 Sep;34(3):698–706. doi: 10.1016/s0735-1097(99)00271-5. [DOI] [PubMed] [Google Scholar]
  23. Drenth Derk J., Winter Jobst B., Veeger Nic J. G. M., Monnink Stefan H. J., van Boven Ad J., Grandjean Jan G., Mariani Massimo A., Boonstra Piet W. Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: six months' angiographic and clinical follow-up of a prospective randomized study. J Thorac Cardiovasc Surg. 2002 Jul;124(1):130–135. doi: 10.1067/mtc.2002.122525. [DOI] [PubMed] [Google Scholar]
  24. Ellis S. G., Tamai H., Nobuyoshi M., Kosuga K., Colombo A., Holmes D. R., Macaya C., Grines C. L., Whitlow P. L., White H. J. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation. 1997 Dec 2;96(11):3867–3872. doi: 10.1161/01.cir.96.11.3867. [DOI] [PubMed] [Google Scholar]
  25. Ferguson James J., Antman Elliott M., Bates Eric R., Cohen Marc, Every Nathan R., Harrington Robert A., Pepine Carl J., Theroux Pierre, NICE-3 Investigators Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J. 2003 Oct;146(4):628–634. doi: 10.1016/S0002-8703(03)00165-0. [DOI] [PubMed] [Google Scholar]
  26. Fischman D. L., Leon M. B., Baim D. S., Schatz R. A., Savage M. P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. doi: 10.1056/NEJM199408253310802. [DOI] [PubMed] [Google Scholar]
  27. Foley D. P., Serruys P. W. Restenosis after percutaneous interventions: the evolving angiographic perspective. Coron Artery Dis. 1993 Dec;4(12):1129–1136. [PubMed] [Google Scholar]
  28. Garbarz E., Iung B., Lefevre G., Makita Y., Farah B., Michaud P., Graine H., Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol. 1999 Sep 1;84(5):515–518. doi: 10.1016/s0002-9149(99)00369-0. [DOI] [PubMed] [Google Scholar]
  29. Gershlick Anthony, De Scheerder Ivan, Chevalier Bernard, Stephens-Lloyd Amanda, Camenzind Edoardo, Vrints Christian, Reifart Nicolaus, Missault Luc, Goy Jean-Jacques, Brinker Jeffrey A. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation. 2004 Jan 26;109(4):487–493. doi: 10.1161/01.CIR.0000109694.58299.A0. [DOI] [PubMed] [Google Scholar]
  30. Gray H. H., Callum K. G. Death following coronary angioplasty. Heart. 2002 Mar;87(3):185–186. doi: 10.1136/heart.87.3.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Grines C. L., Topol E. J., Bates E. R., Juni J. E., Walton J. A., Jr, O'Neill W. W. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. Am Heart J. 1988 Jan;115(1 Pt 1):1–7. doi: 10.1016/0002-8703(88)90510-8. [DOI] [PubMed] [Google Scholar]
  32. Grise Mark A., Massullo Vincent, Jani Shirish, Popma Jeffrey J., Russo Robert J., Schatz Richard A., Guarneri Erminia M., Steuterman Stephen, Cloutier David A., Leon Martin B. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002 Jun 11;105(23):2737–2740. doi: 10.1161/01.cir.0000018126.87045.e0. [DOI] [PubMed] [Google Scholar]
  33. Hamon M., Richardeau Y., Lécluse E., Saloux E., Sabatier R., Agostini D., Filmont J. E., Grollier G., Potier J. C. Direct coronary stenting without balloon predilation in acute coronary syndromes. Am Heart J. 1999 Jul;138(1 Pt 1):55–59. doi: 10.1016/s0002-8703(99)70246-2. [DOI] [PubMed] [Google Scholar]
  34. Herrmann H. C., Moliterno D. J., Ohman E. M., Stebbins A. L., Bode C., Betriu A., Forycki F., Miklin J. S., Bachinsky W. B., Lincoff A. M. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol. 2000 Nov 1;36(5):1489–1496. doi: 10.1016/s0735-1097(00)00923-2. [DOI] [PubMed] [Google Scholar]
  35. Hochman J. S., Sleeper L. A., Webb J. G., Sanborn T. A., White H. D., Talley J. D., Buller C. E., Jacobs A. K., Slater J. N., Col J. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 Aug 26;341(9):625–634. doi: 10.1056/NEJM199908263410901. [DOI] [PubMed] [Google Scholar]
  36. Hong Myeong-Ki, Mintz Gary S., Lee Cheol Whan, Song Jong-Min, Han Ki-Hoon, Kang Duk-Hyun, Song Jae-Kwan, Kim Jae-Joong, Weissman Neil J., Fearnot Neal E. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation. 2003 Feb 4;107(4):517–520. doi: 10.1161/01.cir.0000054163.42072.d4. [DOI] [PubMed] [Google Scholar]
  37. Höher M., Wöhrle J., Grebe O. C., Kochs M., Osterhues H. H., Hombach V., Buchwald A. B. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol. 1999 Sep;34(3):722–729. doi: 10.1016/s0735-1097(99)00254-5. [DOI] [PubMed] [Google Scholar]
  38. IJsselmuiden Alexander J. J., Cotton James M., Slagboom Ton, van der Wieken Ron, Kiemeneij Ferdinand, Serruys Patrick W., Laarman GertJan. Safe and effective direct implantation of a new stent through 5 F. guiding catheters with delivery from the radial artery: initial results of a prospective registry. Int J Cardiovasc Intervent. 2003;5(2):72–76. doi: 10.1080/14628840310003253. [DOI] [PubMed] [Google Scholar]
  39. Iliadis E. A., Zaacks S. M., Calvin J. E., Allen J., Parrillo J. E., Klein L. W. The relative influence of lesion length and other stenosis morphologies on procedural success of coronary intervention. Angiology. 2000 Jan;51(1):39–52. doi: 10.1177/000331970005100108. [DOI] [PubMed] [Google Scholar]
  40. Ivanhoe R. J., Weintraub W. S., Douglas J. S., Jr, Lembo N. J., Furman M., Gershony G., Cohen C. L., King S. B., 3rd Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up. Circulation. 1992 Jan;85(1):106–115. doi: 10.1161/01.cir.85.1.106. [DOI] [PubMed] [Google Scholar]
  41. Izumi M., Tsuchikane E., Funamoto M., Kobayashi T., Sumitsuji S., Otsuji S., Sakurai M., Kobayashi T., Awata N. Final results of the CAPAS trial. Am Heart J. 2001 Nov;142(5):782–789. doi: 10.1067/mhj.2001.119129. [DOI] [PubMed] [Google Scholar]
  42. Juliard J. M., Himbert D., Cristofini P., Desportes J. C., Magne M., Golmard J. L., Aubry P., Benamer H., Boccara A., Karrillon G. J. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty. Am J Cardiol. 1999 Feb 1;83(3):305–310. doi: 10.1016/s0002-9149(98)00858-3. [DOI] [PubMed] [Google Scholar]
  43. Kastrati A., Schömig A., Dirschinger J., Mehilli J., Dotzer F., von Welser N., Neumann F. J. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation. 2000 Nov 21;102(21):2593–2598. doi: 10.1161/01.cir.102.21.2593. [DOI] [PubMed] [Google Scholar]
  44. Kastrati Adnan, Mehilli Julinda, Schühlen Helmut, Dirschinger Josef, Dotzer Franz, ten Berg Jurriën M., Neumann Franz-Josef, Bollwein Hildegard, Volmer Christian, Gawaz Meinrad. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med. 2004 Jan 15;350(3):232–238. doi: 10.1056/NEJMoa031859. [DOI] [PubMed] [Google Scholar]
  45. Keeley Ellen C., Boura Judith A., Grines Cindy L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 Jan 4;361(9351):13–20. doi: 10.1016/S0140-6736(03)12113-7. [DOI] [PubMed] [Google Scholar]
  46. Kelley Michael P., Klugherz Bruce D., Hashemi Seyed M., Meneveau Nicolas F., Johnston Janet M., Matthai William H., Jr, Banka Vidya S., Herrmann Howard C., Hirshfeld John W., Jr, Kimmel Stephen E. One-year clinical outcomes of protected and unprotected left main coronary artery stenting. Eur Heart J. 2003 Sep;24(17):1554–1559. doi: 10.1016/s0195-668x(03)00314-2. [DOI] [PubMed] [Google Scholar]
  47. Kereiakes D. J., Grines C., Fry E., Esente P., Hoppensteadt D., Midei M., Barr L., Matthai W., Todd M., Broderick T. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Cardiol. 2001 Apr;13(4):272–278. [PubMed] [Google Scholar]
  48. Kimmel Stephen E., Sauer William H., Brensinger Colleen, Hirshfeld John, Haber Howard L., Localio A. Russell. Relationship between coronary angioplasty laboratory volume and outcomes after hospital discharge. Am Heart J. 2002 May;143(5):833–840. doi: 10.1067/mhj.2002.122116. [DOI] [PubMed] [Google Scholar]
  49. Kimura Takeshi, Abe Kenichi, Shizuta Satoshi, Odashiro Keita, Yoshida Yoshinori, Sakai Koyu, Kaitani Kazuaki, Inoue Katsumi, Nakagawa Yoshihisa, Yokoi Hiroyoshi. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002 Jun 25;105(25):2986–2991. doi: 10.1161/01.cir.0000019743.11941.3b. [DOI] [PubMed] [Google Scholar]
  50. Kini A., Kini S., Marmur J. D., Bertea T., Dangas G., Cocke T. P., Sharma S. K. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Catheter Cardiovasc Interv. 1999 Oct;48(2):123–129. doi: 10.1002/(sici)1522-726x(199910)48:2<123::aid-ccd1>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  51. Kinoshita I., Katoh O., Nariyama J., Otsuji S., Tateyama H., Kobayashi T., Shibata N., Ishihara T., Ohsawa N. Coronary angioplasty of chronic total occlusions with bridging collateral vessels: immediate and follow-up outcome from a large single-center experience. J Am Coll Cardiol. 1995 Aug;26(2):409–415. doi: 10.1016/0735-1097(95)80015-9. [DOI] [PubMed] [Google Scholar]
  52. Lee Chi Hang, Degertekin Muzaffer, van Domburg Ron T., Foley David P., Smits Pieter, van de Giessen Willem, Vos Joeren, de Feyter Pim, Serruys Patrick W. Impact of different anatomical patterns of left main coronary stenting on long-term survival. Am J Cardiol. 2003 Sep 15;92(6):718–720. doi: 10.1016/s0002-9149(03)00837-3. [DOI] [PubMed] [Google Scholar]
  53. Lefèvre T., Louvard Y., Morice M. C., Dumas P., Loubeyre C., Benslimane A., Premchand R. K., Guillard N., Piéchaud J. F. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv. 2000 Mar;49(3):274–283. doi: 10.1002/(sici)1522-726x(200003)49:3<274::aid-ccd11>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  54. Lincoff A. Michael, Bittl John A., Harrington Robert A., Feit Frederick, Kleiman Neal S., Jackman J. Daniel, Sarembock Ian J., Cohen David J., Spriggs Douglas, Ebrahimi Ramin. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19;289(7):853–863. doi: 10.1001/jama.289.7.853. [DOI] [PubMed] [Google Scholar]
  55. Lincoff A. Michael, Kleiman Neal S., Kottke-Marchant Kandace, Maierson Elizabeth S., Maresh Kelly, Wolski Katherine E., Topol Eric J. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May;143(5):847–853. doi: 10.1067/mhj.2002.122173. [DOI] [PubMed] [Google Scholar]
  56. Loubeyre C., Lefèvre T., Louvard Y., Dumas P., Piéchaud J. F., Lanore J. J., Angellier J. F., Le Tarnec J. Y., Karrillon G., Margenet A. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J. 2001 Jul;22(13):1128–1135. doi: 10.1053/euhj.2000.2500. [DOI] [PubMed] [Google Scholar]
  57. Louvard Y., Lefèvre T., Allain A., Morice M. Coronary angiography through the radial or the femoral approach: The CARAFE study. Catheter Cardiovasc Interv. 2001 Feb;52(2):181–187. doi: 10.1002/1522-726x(200102)52:2<181::aid-ccd1044>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  58. Magid D. J., Calonge B. N., Rumsfeld J. S., Canto J. G., Frederick P. D., Every N. R., Barron H. V., National Registry of Myocardial Infarction 2 and 3 Investigators Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000 Dec 27;284(24):3131–3138. doi: 10.1001/jama.284.24.3131. [DOI] [PubMed] [Google Scholar]
  59. Maillard L., Hamon M., Khalife K., Steg P. G., Beygui F., Guermonprez J. L., Spaulding C. M., Boulenc J. M., Lipiecki J., Lafont A. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol. 2000 Jun;35(7):1729–1736. doi: 10.1016/s0735-1097(00)00612-4. [DOI] [PubMed] [Google Scholar]
  60. Martínez-Elbal L., Ruiz-Nodar J. M., Zueco J., López-Minguez J. R., Moreu J., Calvo I., Ramirez J. A., Alonso M., Vazquez N., Lezaun R. Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries. Eur Heart J. 2002 Apr;23(8):633–640. doi: 10.1053/euhj.2001.2893. [DOI] [PubMed] [Google Scholar]
  61. Maynard C., Every N. R., Chapko M. K., Ritchie J. L. Improved outcomes associated with stenting in the healthcare cost and utilization project. J Interv Cardiol. 2001 Apr;14(2):159–163. doi: 10.1111/j.1540-8183.2001.tb00728.x. [DOI] [PubMed] [Google Scholar]
  62. Mehilli Julinda, Kastrati Adnan, Dirschinger Josef, Dotzer Franz, Pache Jürgen, Hausleiter Jörg, Krämer Wolfgang, Schühlen Helmut, Schömig Albert. Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus. Am J Med. 2002 Jan;112(1):13–18. doi: 10.1016/s0002-9343(01)01010-5. [DOI] [PubMed] [Google Scholar]
  63. Moliterno David J., Yakubov Steven J., DiBattiste Peter M., Herrmann Howard C., Stone Gregg W., Macaya Carlos, Neumann Franz-Josef, Ardissino Diego, Bassand Jean-Pierre, Borzi Lynn. Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet. 2002 Aug 3;360(9330):355–360. doi: 10.1016/S0140-6736(02)09605-8. [DOI] [PubMed] [Google Scholar]
  64. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J. M., Morice M. C., Maillard L., Pansiéri M. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001 Jun 21;344(25):1895–1903. doi: 10.1056/NEJM200106213442503. [DOI] [PubMed] [Google Scholar]
  65. Moon J. C. C., Kalra P. R., Coats A. J. S. DANAMI-2: is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? Int J Cardiol. 2002 Oct;85(2-3):199–201. doi: 10.1016/s0167-5273(02)00183-3. [DOI] [PubMed] [Google Scholar]
  66. Morice Marie-Claude, Serruys Patrick W., Sousa J. Eduardo, Fajadet Jean, Ban Hayashi Ernesto, Perin Marco, Colombo Antonio, Schuler G., Barragan Paul, Guagliumi Giulio. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002 Jun 6;346(23):1773–1780. doi: 10.1056/NEJMoa012843. [DOI] [PubMed] [Google Scholar]
  67. Moses Jeffrey W., Leon Martin B., Popma Jeffrey J., Fitzgerald Peter J., Holmes David R., O'Shaughnessy Charles, Caputo Ronald P., Kereiakes Dean J., Williams David O., Teirstein Paul S. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315–1323. doi: 10.1056/NEJMoa035071. [DOI] [PubMed] [Google Scholar]
  68. Müller Iris, Besta Felicitas, Schulz Christian, Li Zhongyan, Massberg Steffen, Gawaz Meinrad. Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation. 2003 Oct 20;108(18):2195–2197. doi: 10.1161/01.CIR.0000099507.32936.C0. [DOI] [PubMed] [Google Scholar]
  69. Müller Iris, Besta Felicitas, Schulz Christian, Massberg Steffen, Schönig Albert, Gawaz Meinrad. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost. 2003 May;89(5):783–787. [PubMed] [Google Scholar]
  70. Narins C. R., Miller D. P., Califf R. M., Topol E. J. The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. J Am Coll Cardiol. 1999 Mar;33(3):647–653. doi: 10.1016/s0735-1097(98)00620-2. [DOI] [PubMed] [Google Scholar]
  71. Neubauer Horst, Günesdogan Bülent, Hanefeld Christoph, Spiecker Martin, Mügge Andreas. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study. Eur Heart J. 2003 Oct;24(19):1744–1749. doi: 10.1016/s0195-668x(03)00442-1. [DOI] [PubMed] [Google Scholar]
  72. Neumann F. J., Kastrati A., Schmitt C., Blasini R., Hadamitzky M., Mehilli J., Gawaz M., Schleef M., Seyfarth M., Dirschinger J. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol. 2000 Mar 15;35(4):915–921. doi: 10.1016/s0735-1097(99)00635-x. [DOI] [PubMed] [Google Scholar]
  73. Ng William, Chen Wai-Hong, Lee Pui-Yin, Lau Chu-Pak. Initial experience and safety in the treatment of chronic total coronary occlusions with a new optical coherent reflectometry-guided radiofrequency ablation guidewire. Am J Cardiol. 2003 Sep 15;92(6):732–734. doi: 10.1016/s0002-9149(03)00841-5. [DOI] [PubMed] [Google Scholar]
  74. Noguchi T., Miyazaki MD S., Morii I., Daikoku S., Goto Y., Nonogi H. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv. 2000 Mar;49(3):258–264. doi: 10.1002/(sici)1522-726x(200003)49:3<258::aid-ccd7>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  75. Olivari Zoran, Rubartelli Paolo, Piscione Federico, Ettori Federica, Fontanelli Alessandro, Salemme Luigi, Giachero Corinna, Di Mario Carlo, Gabrielli Gabriele, Spedicato Leonardo. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol. 2003 May 21;41(10):1672–1678. doi: 10.1016/s0735-1097(03)00312-7. [DOI] [PubMed] [Google Scholar]
  76. Park S. J., Park S. W., Hong M. K., Cheong S. S., Lee C. W., Kim J. J., Hong M. K., Mintz G. S., Leon M. B. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol. 1998 Jan;31(1):37–42. doi: 10.1016/s0735-1097(97)00425-7. [DOI] [PubMed] [Google Scholar]
  77. Parker D. J., Gray H. H., Balcon R., Birkhead J. S., Boyle R. M., Hutton I., Parsons L., Rothman M. T., Shaw T. R. Planning for coronary angioplasty: guidelines for training and continuing competence. British Cardiac Society (BCS) and British Cardiovascular Intervention Society (BCIS) working group on interventional cardiology. Heart. 1996 Apr;75(4):419–425. doi: 10.1136/hrt.75.4.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Perez de Arenaza Diego, Taneja Anil K., Flather Marcus. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial). Eur Heart J. 2003 Oct;24(19):1798–1798. doi: 10.1016/j.ehj.2003.06.001. [DOI] [PubMed] [Google Scholar]
  79. Pijls Nico H. J., Klauss Volker, Siebert Uwe, Powers Eric, Takazawa Kenji, Fearon William F., Escaned Javier, Tsurumi Yukio, Akasaka Takashi, Samady Habib. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950–2954. doi: 10.1161/01.cir.0000020547.92091.76. [DOI] [PubMed] [Google Scholar]
  80. Puma J. A., Sketch M. H., Jr, Tcheng J. E., Harrington R. A., Phillips H. R., Stack R. S., Califf R. M. Percutaneous revascularization of chronic coronary occlusions: an overview. J Am Coll Cardiol. 1995 Jul;26(1):1–11. doi: 10.1016/0735-1097(95)00156-t. [DOI] [PubMed] [Google Scholar]
  81. Riess Friedrich-Christian, Bader Ralf, Kremer Peter, Kühn Clemens, Kormann Joachim, Mathey Detlef, Moshar Sina, Tuebler Thilo, Bleese Niels, Schofer Joachim. Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg. 2002 Jun;73(6):1849–1855. doi: 10.1016/s0003-4975(02)03519-1. [DOI] [PubMed] [Google Scholar]
  82. Rodriguez A., Bernardi V., Navia J., Baldi J., Grinfeld L., Martinez J., Vogel D., Grinfeld R., Delacasa A., Garrido M. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol. 2001 Jan;37(1):51–58. doi: 10.1016/s0735-1097(00)01052-4. [DOI] [PubMed] [Google Scholar]
  83. Ross A. M., Coyne K. S., Reiner J. S., Greenhouse S. W., Fink C., Frey A., Moreyra E., Traboulsi M., Racine N., Riba A. L. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol. 1999 Dec;34(7):1954–1962. doi: 10.1016/s0735-1097(99)00444-1. [DOI] [PubMed] [Google Scholar]
  84. Sandborg Michael, Fransson Sven-Göran, Pettersson Håkan. Evaluation of patient-absorbed doses during coronary angiography and intervention by femoral and radial artery access. Eur Radiol. 2003 Nov 14;14(4):653–658. doi: 10.1007/s00330-003-2120-4. [DOI] [PubMed] [Google Scholar]
  85. Saw Jacqueline, Steinhubl Steven R., Berger Peter B., Kereiakes Dean J., Serebruany Victor L., Brennan Danielle, Topol Eric J., Clopidogrel for the Reduction of Events During Observation Investigators Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation. 2003 Aug 18;108(8):921–924. doi: 10.1161/01.CIR.0000088780.57432.43. [DOI] [PubMed] [Google Scholar]
  86. Schofer Joachim, Schlüter Michael, Gershlick Anthony H., Wijns William, Garcia Eulogio, Schampaert Erick, Breithardt Günter, E-SIRIUS Investigators Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003 Oct 4;362(9390):1093–1099. doi: 10.1016/S0140-6736(03)14462-5. [DOI] [PubMed] [Google Scholar]
  87. Schömig A., Kastrati A., Dirschinger J., Mehilli J., Schricke U., Pache J., Martinoff S., Neumann F. J., Schwaiger M. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med. 2000 Aug 10;343(6):385–391. doi: 10.1056/NEJM200008103430602. [DOI] [PubMed] [Google Scholar]
  88. Serruys P. W., Unger F., van Hout B. A., van den Brand M. J., van Herwerden L. A., van Es G. A., Bonnier J. J., Simon R., Cremer J., Colombo A. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999 Dec;4(4):209–219. doi: 10.1006/siic.1999.0107. [DOI] [PubMed] [Google Scholar]
  89. Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. doi: 10.1056/NEJM199408253310801. [DOI] [PubMed] [Google Scholar]
  90. Seybert Amy L. Bivalirudin administration during percutaneous coronary intervention: emphasis on high-risk patients. Pharmacotherapy. 2002 Jun;22(6 Pt 2):112S–118S. doi: 10.1592/phco.22.10.112s.33619. [DOI] [PubMed] [Google Scholar]
  91. Shaw Richard E., Anderson H. Vernon, Brindis Ralph G., Krone Ronald J., Klein Lloyd W., McKay Charles R., Block Peter C., Shaw Leslee J., Hewitt Kathleen, Weintraub William S. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol. 2002 Apr 3;39(7):1104–1112. doi: 10.1016/s0735-1097(02)01731-x. [DOI] [PubMed] [Google Scholar]
  92. Sirnes P. A., Golf S., Myreng Y., Mølstad P., Emanuelsson H., Albertsson P., Brekke M., Mangschau A., Endresen K., Kjekshus J. Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol. 1996 Nov 15;28(6):1444–1451. doi: 10.1016/s0735-1097(96)00349-x. [DOI] [PubMed] [Google Scholar]
  93. Steinhubl Steven R., Berger Peter B., Mann J. Tift, 3rd, Fry Edward T. A., DeLago Augustin, Wilmer Charles, Topol Eric J., CREDO Investigators. Clopidogrel for the Reduction of Events During Observation Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002 Nov 20;288(19):2411–2420. doi: 10.1001/jama.288.19.2411. [DOI] [PubMed] [Google Scholar]
  94. Stone G. W., Grines C. L., Browne K. F., Marco J., Rothbaum D., O'Keefe J., Hartzler G. O., Overlie P., Donohue B., Chelliah N. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol. 1995 Feb;25(2):370–377. doi: 10.1016/0735-1097(94)00367-y. [DOI] [PubMed] [Google Scholar]
  95. Stone G. W., Grines C. L., Rothbaum D., Browne K. F., O'Keefe J., Overlie P. A., Donohue B. C., Chelliah N., Vlietstra R., Catlin T. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol. 1997 Apr;29(5):901–907. doi: 10.1016/s0735-1097(97)00041-7. [DOI] [PubMed] [Google Scholar]
  96. Stone Gregg W., Ellis Stephen G., Cox David A., Hermiller James, O'Shaughnessy Charles, Mann James Tift, Turco Mark, Caputo Ronald, Bergin Patrick, Greenberg Joel. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15;350(3):221–231. doi: 10.1056/NEJMoa032441. [DOI] [PubMed] [Google Scholar]
  97. Stone Gregg W., Grines Cindy L., Cox David A., Garcia Eulogio, Tcheng James E., Griffin John J., Guagliumi Giulio, Stuckey Thomas, Turco Mark, Carroll John D. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002 Mar 28;346(13):957–966. doi: 10.1056/NEJMoa013404. [DOI] [PubMed] [Google Scholar]
  98. Stone Gregg W., Rogers Campbell, Hermiller James, Feldman Robert, Hall Patrick, Haber Robert, Masud A., Cambier Patrick, Caputo Ron P., Turco Mark. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003 Jul 21;108(5):548–553. doi: 10.1161/01.CIR.0000080894.51311.0A. [DOI] [PubMed] [Google Scholar]
  99. Suero J. A., Marso S. P., Jones P. G., Laster S. B., Huber K. C., Giorgi L. V., Johnson W. L., Rutherford B. D. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001 Aug;38(2):409–414. doi: 10.1016/s0735-1097(01)01349-3. [DOI] [PubMed] [Google Scholar]
  100. Tan K. H., Sulke N., Taub N. A., Watts E., Karani S., Sowton E. Determinants of success of coronary angioplasty in patients with a chronic total occlusion: a multiple logistic regression model to improve selection of patients. Br Heart J. 1993 Aug;70(2):126–131. doi: 10.1136/hrt.70.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Topol E. J., Moliterno D. J., Herrmann H. C., Powers E. R., Grines C. L., Cohen D. J., Cohen E. A., Bertrand M., Neumann F. J., Stone G. W. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001 Jun 21;344(25):1888–1894. doi: 10.1056/NEJM200106213442502. [DOI] [PubMed] [Google Scholar]
  102. Toutouzas Konstantinos, Stankovic Goran, Takagi Takuro, Albiero Remo, Corvaja Nicola, Milici Caterina, Di Mario Carlo, Finci Leo, Colombo Antonio. A new dedicated stent and delivery system for the treatment of bifurcation lesions: preliminary experience. Catheter Cardiovasc Interv. 2003 Jan;58(1):34–42. doi: 10.1002/ccd.10345. [DOI] [PubMed] [Google Scholar]
  103. Urban P., Serruys P., Baumgart D., Colombo A., Silber S., Eeckhout E., Gershlick A., Wegscheider K., Verhees L., Bonan R. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J. 2003 Apr;24(7):604–612. doi: 10.1016/s0195-668x(02)00617-6. [DOI] [PubMed] [Google Scholar]
  104. Weaver W. D., Simes R. J., Betriu A., Grines C. L., Zijlstra F., Garcia E., Grinfeld L., Gibbons R. J., Ribeiro E. E., DeWood M. A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997 Dec 17;278(23):2093–2098. [PubMed] [Google Scholar]
  105. Webb John G., Lowe April M., Sanborn Timothy A., White Harvey D., Sleeper Lynn A., Carere Ronald G., Buller Christopher E., Wong S. Chiu, Boland Jean, Dzavik Vlad. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003 Oct 15;42(8):1380–1386. doi: 10.1016/s0735-1097(03)01050-7. [DOI] [PubMed] [Google Scholar]
  106. Whitbourn Robert J., Cincotta Marion, Mossop Peter, Selmon Matthew. Intraluminal blunt microdissection for angioplasty of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2003 Feb;58(2):194–198. doi: 10.1002/ccd.10402. [DOI] [PubMed] [Google Scholar]
  107. Widimský P., Groch L., Zelízko M., Aschermann M., Bednár F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000 May;21(10):823–831. doi: 10.1053/euhj.1999.1993. [DOI] [PubMed] [Google Scholar]
  108. Ziakas A. A., Klinke B. P., Mildenberger C. R., Fretz D. E., Williams E. M. B., Kinloch F. R. D., Hilton j G. J. D. Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study. Am Heart J. 2003 Oct;146(4):699–704. doi: 10.1016/S0002-8703(03)00258-8. [DOI] [PubMed] [Google Scholar]
  109. de Feyter P. J., Serruys P. W., Unger F., Beyar R., de Valk V., Milo S., Simon R., Regensburger D., Crean P. A., McGovern E. Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation. 2002 May 21;105(20):2367–2372. doi: 10.1161/01.cir.0000016643.34907.17. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only appendices]
heart_91_suppl-6_vi1_v2_index.html (1.8KB, html)

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES